Join to View Full Profile
1240 Lee StCharlottesville, VA 22908
Phone+1 434-924-9333
Fax+1 434-243-6086
Dr. Keng is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Education & Training
Cleveland Clinic FoundationFellowship, Hematology and Medical Oncology, 2011 - 2014
University of Southern California/Los Angeles General Medical Center (USC/LA General)Residency, Internal Medicine, 2007 - 2010
Michigan State University College of Human MedicineClass of 2007
Certifications & Licensure
CA State Medical License 2008 - Present
VA State Medical License 2014 - 2026
MI State Medical License 2010 - 2014
OH State Medical License 2011 - 2014
American Board of Internal Medicine Internal Medicine- American Board of Internal Medicine Hematology
- American Board of Internal Medicine Medical Oncology
Clinical Trials
Publications & Presentations
PubMed
- The oral CDK9 inhibitor voruciclib combined with venetoclax for patients with relapsed/refractory acute myeloid leukemia.Yesid Alvarado-Valero, Rachel J Cook, Shira N Dinner, Michael Keng, Kebede H Begna
Blood Neoplasia. 2025-08-01 - Real-world analysis of strategies to prevent thrombosis and bleeding in adults with ALL treated with asparaginase.Joseph F Mort, David Brighton, Benjamin Mautner, Eric Pierce, Farid Ghamsari
Blood Vessels, Thrombosis & Hemostasis. 2025-08-01 - Development and Implementation of Oral Anticancer Agent Tools for a Thematic Quality Improvement Program: A Collaboration Between Hematology Oncology Pharmacist Associ...Victoria Nachar, Marjorie Adams Curry, Diana Kostoff, Angela Wood, Karen B Farris
JCO Oncology Practice. 2025-07-01
Abstracts/Posters
- Distance Does Not Matter: Excellent Survival Outcomes for Leukemia Patients in Rural AppalachiaMichael K Keng, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/9/2019
- Clinical and Immunologic Activity of Ipilimumab Following Decitabine Priming in Post-Allogeneic Transplant and Transplant-Na¥ve Patients with Relapsed or Refractory My...Michael Keng, 61st Annual American Society of Hematology Meeting, Orlando, FL, 12/7/2019
Press Mentions
It's Time to Take Action on Quality Improvement MeasuresOctober 21st, 2016
Download Clinical Vignette and Research Abstract CompendiumJanuary 16th, 2018
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
